API
< Back to situations

[ORGANIZATION]

Dr. Reddy’s Farmacêutica do Brasil

Featured in 1 tracked story · first seen

Situations

[QUIET] [HEALTH] [BR] [IN]

Anvisa approval of GLP-1 medications in Brazil

2 clusters · 38 sources · last updated

Latest: Anvisa approves five new injectable pens for diabetes and obesity

Brazil’s National Health Surveillance Agency (Anvisa) has approved the registration of five new GLP-1 receptor agonist medication pens for treating diabetes and obesity. These new products include Aribet, Lyrza, and Wylo